Replay available

Abeona Therapeutics Inc. (ABEO) Q4 2025 Earnings Call

Abeona Therapeutics Inc. (NASDAQ: ABEO) Q4 2025 earnings conference call, held 2026-03-17. Replay captured from the company's public earnings webcast.

Tue, March 17, 2026 at 8:30 AMendedReplay
Abeona Therapeutics Inc. (ABEO) Q4 2025 Earnings Call

Hosted by

Featured presenters

Dr. Vish Seshadri

Chief Executive Officer

Dr. Madhav Vasanthavada

Chief Commercial Officer

Joe Vazano

Chief Financial Officer

Brian Keveny

Chief Technical Officer

Ram Selvaraju

Analyst, HC Wainwright

Maury Raycroft

Analyst, Jefferies

Stephen Willey

Analyst, Stiefel

Kristen Kliska

Analyst, Cantor Fitzgerald

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Abeona Therapeutics Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:05.339 Good morning everyone and welcome to the Abiona Therapeutics 00:00:05.339 -- 00:00:10.486 full year 2025 results conference call. At this time 00:00:10.486 -- 00:00:16.054 all participants are in a listen only mode and the floor will be open for questions 00:00:16.054 -- 00:00:18.057 following the presentation. 00:00:18.057 -- 00:00:23.125 If anyone should require operator assistance during this conference please press 00:00:23.125 -- 00:00:29.073 star zero on your phone keypad. Please note this conference is being recorded. 00:00:29.073 -- 00:00:33.998 During this call, we will refer to the press release issued this morning announcing the 00:00:33.998 -- 00:00:40.623 financial results, which is available on our corporate website at www.abionatherapeutics.com. 00:00:42.267 -- 00:00:47.153 We anticipate making projections and forward-looking statements during today's call, 00:00:47.153 -- 00:00:52.999 which are made pursuant to the safe harbor provisions of the federal securities law. 00:00:52.999 -- 00:00:57.924 These forward-looking statements are based on current expectations and are subject to 00:00:57.924 -- 00:01:03.182 change. Actual results may differ materially from those expressed or implied in 00:01:03.182 -- 00:01:08.249 the forward-looking statements due to various factors, including but not limited to 00:01:08.249 -- 00:01:13.856 those outlined in our Form 10-K and periodic reports filed 00:01:13.856 -- 00:01:16.639 with the Security and Exchange Commission. 00:01:16.639 -- 00:01:22.424 These documents are available on our website at www.abionatherapeutics.com. 00:01:24.269 -- 00:01:28.462 Joining us on today's call with prepared remarks are Dr. 00:01:28.462 -- 00:01:32.006 Vish Seshadri, Chief Executive Officer, and D...